In the present study, we investigated the tumor DNA-PKcs expression in patients with HCC, including those with underlying hepatitis B and/or hepatitis C. We performed a comprehensive immunohistochemical analysis using a specific antibody against DNA-PKcs. Here, PRKDC is linked to neoplasm.